Clinical Trial Update: A Phase 2 Study of Trabectedin (Yondelis) in Adult Male Participants With Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of trabectedin (Yondelis) in adult male participants with advanced prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Yondelis (trabectedin)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED